Traditional Chinese medicine for precancerous lesions of gastric cancer: A review

Biomed Pharmacother. 2022 Feb:146:112542. doi: 10.1016/j.biopha.2021.112542. Epub 2021 Dec 20.

Abstract

Gastric cancer (GC) is the fifth most common type of cancer and the third leading cause of death due to cancer worldwide. The gastric mucosa often undergoes many years of precancerous lesions of gastric cancer (PLGC) stages before progressing to gastric malignancy. Unfortunately, there are no effective Western drugs for patients with PLGC. In recent years, traditional Chinese medicine (TCM) has been proven effective in treating PLGC. Classical TCM formulas and chemical components isolated from some Chinese herbal medicines have been administered to treat PLGC, and the main advantage is their comprehensive intervention with multiple approaches and multiple targets. In this review, we focus on recent studies using TCM treatment for PLGC, including clinical observations and experimental research, with a focus on targets and mechanisms of drugs. This review provides some ideas and a theoretical basis for applying TCM to treat PLGC and prevent GC.

Keywords: Formulas; Pattern differentiation; Pharmacological mechanism; Precancerous lesions of gastric cancer; Traditional Chinese medicine.

Publication types

  • Review

MeSH terms

  • Drugs, Chinese Herbal* / pharmacology
  • Drugs, Chinese Herbal* / therapeutic use
  • Gastric Mucosa
  • Humans
  • Medicine, Chinese Traditional
  • Precancerous Conditions* / drug therapy
  • Precancerous Conditions* / pathology
  • Stomach Neoplasms* / pathology

Substances

  • Drugs, Chinese Herbal